US 7919613
RNAi modulation of SCAP and therapeutic uses thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 7919613 (RNAi modulation of SCAP and therapeutic uses thereof) held by The Board of Regents of the University of Texas System expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P3/00, A61P3/04